$TNXP The new Montana facility is intended to develop and produce Tonix's vaccine candidates, including TNX-1800, a potential COVID-19 vaccine.COMMERCIAL SCALE VACCINE MANUFACTURING FACILITY ADVANCES IN THE BITTERROOT
